logo
Select company
Select metric
0.42Price to Sales
VS
Market
88
Sector
93
Industry
98
History
92
$ 0.54Close
$ 0.39 - $ 1.72 52-Week Range
Ticker Information

Ticker

IPSC

Company Name

CENTURY THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CENTURY THERAPEUTICS INC - Price to Sales Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

IPSC - P/S Historical data
DateMarket CapitalizationPrice to SalesRevenues
6/30/2025$ 47.51M0.42$ 114.13M
3/31/2025$ 44.54M0.39$ 114.9M
12/31/2024$ 50.16M7.61$ 6.59M
9/30/2024$ 113.09M42.12$ 2.69M
6/30/2024$ 152.49M74.68$ 2.04M
3/31/2024$ 251.86M183.84$ 1.37M
12/31/2023$ 292.33M130.8$ 2.23M
9/30/2023$ 83.17M33.43$ 2.49M
6/30/2023$ 170.33M37.32$ 4.56M
3/31/2023$ 200.79M34.26$ 5.86M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CENTURY THERAPEUTICS INC's latest trailing twelve months (TTM) P/S stands at 0.
  • Over the past 5 years, CENTURY THERAPEUTICS INC's average P/S has been 106.89.
  • The median P/S for CENTURY THERAPEUTICS INC during this period was 43.71
  • CENTURY THERAPEUTICS INC reached its highest P/S over the past 5 years at 492.83.
  • The lowest P/S recorded by CENTURY THERAPEUTICS INC in the same timeframe 0.39

CENTURY THERAPEUTICS INC's P/S vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

P/S Benchmarks
CompanyP/S
STRO : SUTRO BIOPHARMA INC 0.65KPTI : KARYOPHARM THERAPEUTICS INC 0.24FBIO : FORTRESS BIOTECH INC 0.98IGMS : IGM BIOSCIENCES INC 0.53VERU : VERU INC 6.98MRSN : MERSANA THERAPEUTICS INC 0.98ADAP : ADAPTIMMUNE THERAPEUTICS PLC 0.32XCUR : EXICURE INC -ATNM : ACTINIUM PHARMACEUTICALS INC -ALGS : ALIGOS THERAPEUTICS INC 15.58

Definition of Price to Sales

[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
Market Cap / Revenues
(=) P/S
P/S for CENTURY THERAPEUTICS INC is calculated as follows: Market Cap [ $ 0 ] / Revenues [ $ 0 ]
(=) P/S [ 0 ]

IPSC - Price to Sales, Last 5 years

0.39

Minimum

Mar 31, 2025

492.83

Maximum

Mar 31, 2022

106.89

Average

43.71

Median

P/S Benchmark Analysis

The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
filtered constituents3.42K
min0
max11.15
average2.62
median1.97
std2.38